secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2022-08-29T23:59:59+00:00
Accession:  0001193125-22-232894
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 1.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD appoints Rubric Capital partner Justin Roberts to board of directors
--------------------------------------------------------------------------------

- Justin Roberts, Partner at Rubric Capital Management, appointed to fill newly created Board seat effective Aug. 23, 2022.
- Board size increased to nine directors; Roberts will stand for election at 2022 Annual Meeting.
- Rubric recently invested $15M in TherapeuticsMD via private placement of Series A Preferred and common stock (July 29, 2022).
- Roberts has elected not to receive any director compensation at this time.
- No other arrangements or material transactions between Roberts and Company beyond the Rubric investment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312522232894/0001193125-22-232894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312522232894/d742359d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-232894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer